1.41
price up icon4.44%   0.06
pre-market  Pre-market:  1.41  
loading

An 2 Therapeutics Inc Stock (ANTX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
2.76%
18.30
18.82 18.18 16.60 16.04
Operating Income/Loss
2.76%
-18.30
-18.82 -18.18 -16.60 -16.04
Income/Loss From Continuing Operations Before Tax
1.66%
-16.62
-16.90 -16.71 -15.80 -15.32
Income/Loss From Continuing Operations After Tax
1.66%
-16.62
-16.90 -16.71 -15.80 -15.32
Net Income/Loss
1.66%
-16.62
-16.90 -16.71 -15.80 -15.32
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,340%
29.76
2.0676 25.65 19.50 19.39
Diluted Average Shares
1,340%
29.76
2.0676 25.65 19.50 19.39
Basic Earnings Per Share
7.69%
-0.56
-0.52 -0.65 -0.81 -0.79
Diluted Earnings Per Share
7.69%
-0.56
-0.52 -0.65 -0.81 -0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):